DiscoverKeeping Current CMEESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?
ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

Update: 2025-11-04
Share

Description

Is your patient progressing on an aromatase inhibitor (AI)? Fine-tune ddPCR/NGS testing to detect resistance and optimize oral selective estrogen receptor degrader (SERD) success.

Credit available for this activity expires: 11/04/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/esr1-mutation-testing-breast-cancer-setting-standard-2025a1000u0f?ecd=bdc_podcast_libsyn_mscpedu

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?